Acta Materia Medica provides an open platform for rapid publication of the latest findings, approaches, and viewpoints related to all related areas of pharmacy and pharmaceutical sciences, including, but are not limited to, pharmacology, toxicology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, pharmacokinetics, clinical pharmacy, pharmacoepidemiology, pharmacoeconomics and pharmacy management.
Article types accepted:
- Research articles
- Review articles
- Databases
- Mini reviews
- Commentaries
- Editorials
- Short communications
- Case report articles
- Study protocols.
Submissions: Articles can be submitted to Acta Materia Medica using ScholarOne, the online submission and peer review system. Registration and access are available at https://mc04.manuscriptcentral.com/ammed
Editorial Board: https://amm-journal.org/index.php/editorial-board/
For more information about the journal, including article submission guidelines and how to register for free content-alerting services, please visit: https://amm-journal.org/
Acta Materia Medica is now open for submissions via ScholarOne (https://mc04.manuscriptcentral.com/ammed).
There are no author submission or article processing fees.
Please visit https://amm-journal.org/ to learn more about the journal.
Editorial Board: https://amm-journal.org/index.php/editorial-board/
Twitter: @AMM_journal
eISSN 2737-7946
Articles of interest include:
Drug discovery is an eternal challenge for the biomedical sciences
Regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer’s disease
Advances in therapeutic agents targeting quiescent cancer cells
Ligands for oral delivery of peptides across the blood-brain-barrier
PROTAC technology for the treatment of Alzheimer’s disease: advances and perspectives
PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective
Research progress in 3D-printed medicinal tablets
Structure prediction of the entire proteome of monkeypox variants